Nanobodies TM targeting amyloid beta as potential therapeutics for Alzheimer's disease

From National Research Council Canada

AuthorSearch for: ; Search for: ; Search for: ; Search for: 1; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: ; Search for:
Affiliation
  1. National Research Council of Canada. NRC Institute for Biological Sciences
FormatText, Article
Subjectamyloid beta; Alzheimer's disease; aanobodies; passive immunotherapy
Abstract
LanguageEnglish
Peer reviewedYes
NPARC number21275177
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier80d443d9-e752-4846-96d9-b7d20f33225c
Record created2015-05-22
Record modified2020-04-22
Date modified: